Product Code: TMRGL16340
Dental Membrane & Bone Graft Substitutes Market - Scope of Report
TMR's report on the global Dental Membrane & Bone Graft Substitutes Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Dental Membrane & Bone Graft Substitutes Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Dental Membrane & Bone Graft Substitutes Market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Dental Membrane & Bone Graft Substitutes Market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Dental Membrane & Bone Graft Substitutes Market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Dental Membrane & Bone Graft Substitutes Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Dental Membrane & Bone Graft Substitutes Market.
The report delves into the competitive landscape of the global Dental Membrane & Bone Graft Substitutes Market. Key players operating in the global Dental Membrane & Bone Graft Substitutes Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Dental Membrane & Bone Graft Substitutes Market profiled in this report.
Key Questions Answered in Global Dental Membrane & Bone Graft Substitutes Market Report:
- What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
- What are the opportunities in the global Dental Membrane & Bone Graft Substitutes Market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Dental Membrane & Bone Graft Substitutes Market - Research Objectives and Research Approach
The comprehensive report on the global Dental Membrane & Bone Graft Substitutes Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Dental Membrane & Bone Graft Substitutes Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Dental Membrane & Bone Graft Substitutes.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Membrane & Bone Graft Substitutes Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Emerging Trends In Dental Bone Graft
- 5.3. Regulatory Scenario by Region/Globally
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Dental Membrane
- 6.3.1.1. Resorbable
- 6.3.1.2. Non-resorbable
- 6.3.2. Dental Bone Graft
- 6.3.2.1. Autograft
- 6.3.2.2. Allograft
- 6.3.2.3. Demineralized Bone Matrix
- 6.3.2.4. Xenograft
- 6.3.2.5. Synthetic Bone Graft Substitute
- 6.4. Market Attractiveness Analysis, by Product
7. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Material
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Material, 2017-2031
- 7.3.1. Hydrogel
- 7.3.2. Collagen
- 7.3.3. Polytetrafluoroethylene (PTFE)
- 7.3.4. Human Cells Sources
- 7.3.5. Hydroxyapatite (HA)
- 7.3.6. Tricalcium Phosphate (TCP)
- 7.3.7. Other Species
- 7.4. Market Attractiveness Analysis, by Material
8. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Dental Clinics
- 8.3.2.1. Individual Practice
- 8.3.2.2. Group Practice
- 8.3.3. Ambulatory Surgical Centers
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Dental Membrane
- 10.2.1.1. Resorbable
- 10.2.1.2. Non-resorbable
- 10.2.2. Dental Bone Graft
- 10.2.2.1. Autograft
- 10.2.2.2. Allograft
- 10.2.2.3. Demineralized Bone Matrix
- 10.2.2.4. Xenograft
- 10.2.2.5. Synthetic Bone Graft Substitute
- 10.3. Market Value Forecast, by Material, 2017-2031
- 10.3.1. Hydrogel
- 10.3.2. Collagen
- 10.3.3. Polytetrafluoroethylene (PTFE)
- 10.3.4. Human Cells Sources
- 10.3.5. Hydroxyapatite (HA)
- 10.3.6. Tricalcium Phosphate (TCP)
- 10.3.7. Other Species
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Dental Clinics
- 10.4.2.1. Individual Practice
- 10.4.2.2. Group Practice
- 10.4.3. Ambulatory Surgical Centers
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Material
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Dental Membrane
- 11.2.1.1. Resorbable
- 11.2.1.2. Non-resorbable
- 11.2.2. Dental Bone Graft
- 11.2.2.1. Autograft
- 11.2.2.2. Allograft
- 11.2.2.3. Demineralized Bone Matrix
- 11.2.2.4. Xenograft
- 11.2.2.5. Synthetic Bone Graft Substitute
- 11.3. Market Value Forecast, by Material, 2017-2031
- 11.3.1. Hydrogel
- 11.3.2. Collagen
- 11.3.3. Polytetrafluoroethylene (PTFE)
- 11.3.4. Human Cells Sources
- 11.3.5. Hydroxyapatite (HA)
- 11.3.6. Tricalcium Phosphate (TCP)
- 11.3.7. Other Species
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Dental Clinics
- 11.4.2.1. Individual Practice
- 11.4.2.2. Group Practice
- 11.4.3. Ambulatory Surgical Centers
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Material
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Dental Membrane
- 12.2.1.1. Resorbable
- 12.2.1.2. Non-resorbable
- 12.2.2. Dental Bone Graft
- 12.2.2.1. Autograft
- 12.2.2.2. Allograft
- 12.2.2.3. Demineralized Bone Matrix
- 12.2.2.4. Xenograft
- 12.2.2.5. Synthetic Bone Graft Substitute
- 12.3. Market Value Forecast, by Material, 2017-2031
- 12.3.1. Hydrogel
- 12.3.2. Collagen
- 12.3.3. Polytetrafluoroethylene (PTFE)
- 12.3.4. Human Cells Sources
- 12.3.5. Hydroxyapatite (HA)
- 12.3.6. Tricalcium Phosphate (TCP)
- 12.3.7. Other Species
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Dental Clinics
- 12.4.2.1. Individual Practice
- 12.4.2.2. Group Practice
- 12.4.3. Ambulatory Surgical Centers
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Material
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Dental Membrane
- 13.2.1.1. Resorbable
- 13.2.1.2. Non-resorbable
- 13.2.2. Dental Bone Graft
- 13.2.2.1. Autograft
- 13.2.2.2. Allograft
- 13.2.2.3. Demineralized Bone Matrix
- 13.2.2.4. Xenograft
- 13.2.2.5. Synthetic Bone Graft Substitute
- 13.3. Market Value Forecast, by Material, 2017-2031
- 13.3.1. Hydrogel
- 13.3.2. Collagen
- 13.3.3. Polytetrafluoroethylene (PTFE)
- 13.3.4. Human Cells Sources
- 13.3.5. Hydroxyapatite (HA)
- 13.3.6. Tricalcium Phosphate (TCP)
- 13.3.7. Other Species
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Dental Clinics
- 13.4.2.1. Individual Practice
- 13.4.2.2. Group Practice
- 13.4.3. Ambulatory Surgical Centers
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Material
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Membrane & Bone Graft Substitutes Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Dental Membrane
- 14.2.1.1. Resorbable
- 14.2.1.2. Non-resorbable
- 14.2.2. Dental Bone Graft
- 14.2.2.1. Autograft
- 14.2.2.2. Allograft
- 14.2.2.3. Demineralized Bone Matrix
- 14.2.2.4. Xenograft
- 14.2.2.5. Synthetic Bone Graft Substitute
- 14.3. Market Value Forecast, by Material, 2017-2031
- 14.3.1. Hydrogel
- 14.3.2. Collagen
- 14.3.3. Polytetrafluoroethylene (PTFE)
- 14.3.4. Human Cells Sources
- 14.3.5. Hydroxyapatite (HA)
- 14.3.6. Tricalcium Phosphate (TCP)
- 14.3.7. Other Species
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Dental Clinics
- 14.4.2.1. Individual Practice
- 14.4.2.2. Group Practice
- 14.4.3. Ambulatory Surgical Centers
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Material
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company (2022)
- 15.3. Company Profiles
- 15.3.1. ACE Surgical Supply Co., Inc.
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. Botiss Biomaterials GmbH
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Collagen Matrix, Inc.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. CURASAN AG
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. Dentsply Sirona
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.5.5. Strategic Overview
- 15.3.6. Geistlich Pharma
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.6.5. Strategic Overview
- 15.3.7. KLS Martin Group
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.7.5. Strategic Overview
- 15.3.8. LifeNet Health
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.8.5. Strategic Overview
- 15.3.9. Medtronic plc
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.9.5. Strategic Overview
- 15.3.10. NovaBone Products LLC
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. Financial Overview
- 15.3.10.4. SWOT Analysis
- 15.3.10.5. Strategic Overview
- 15.3.11. Osteogenics Biomedical
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Product Portfolio
- 15.3.11.3. Financial Overview
- 15.3.11.4. SWOT Analysis
- 15.3.11.5. Strategic Overview
- 15.3.12. RTI Surgical Holdings, Inc.
- 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.12.2. Product Portfolio
- 15.3.12.3. Financial Overview
- 15.3.12.4. SWOT Analysis
- 15.3.12.5. Strategic Overview
- 15.3.13. Salvin Dental Specialties, Inc.
- 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.13.2. Product Portfolio
- 15.3.13.3. Financial Overview
- 15.3.13.4. SWOT Analysis
- 15.3.13.5. Strategic Overview
- 15.3.14. Straumann Group
- 15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.14.2. Product Portfolio
- 15.3.14.3. Financial Overview
- 15.3.14.4. SWOT Analysis
- 15.3.14.5. Strategic Overview
- 15.3.15. Zimmer Biomet Holdings, Inc.
- 15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.15.2. Product Portfolio
- 15.3.15.3. Financial Overview
- 15.3.15.4. SWOT Analysis
- 15.3.15.5. Strategic Overview